Ellison Institute of Technology (EITM)

Los Angeles, California 90064

1 studies enrolling now · 1 studies all time

What they study most

Triple Negative Breast Cancer

Studies at this site

• Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients — Recruiting now